Skip to content

Respiratory Muscle Training in Patients with Chronic Kidney Disease Undergoing Hemodialysis Therapy

Inspiratory muscle training in patients with chronic kidney disease on hemodialysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3pxj3m
Enrollment
Unknown
Registered
2015-04-01
Start date
2013-05-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure Terminal

Interventions

Intervention group: 13 patients randomly assigned will be submitted to inspiratory muscle training (IMT) with load 30% of maximal inspiratory muscle strength (PImáx) with duration of 30 minutes, three
Other
E02.190.525.186

Sponsors

Universidade de Passo Fundo
Lead Sponsor
Universidade de Passo Fundo
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients of both sexes, who undertake hemodialysis three times a week, for a minimum period of three months, which are not physically active, showing reduction in inspiratory muscle strength (PImáx <70% predicted), and have signed the term of free and informed consent (TCLE).

Exclusion criteria

Exclusion criteria: Hemodynamic instability, amputation, deep vein thrombosis, severe dyspnea, femoral fistula, chest pain, unstable angina, active liver disease, orthopedic impairments, musculoskeletal, neurological and / or cognitive changes that compromise the participation in the proposed protocol, or even those individuals who refusing to sign the consent form free and enlightened (TCLE).

Design outcomes

Primary

MeasureTime frame
Respiratory muscle strength as measured by analog manometer, according with the Brazilian consensus and the limit values for the Brazilian population.;Expected outcome: Improved value of PImáx and PEmáx (inspiratory and expiratory maxima pressure). Outcome found: There was improvement in PImáx and PEmáx values in both groups (intervention and control-Sham), but not significant when compared between groups.

Secondary

MeasureTime frame
1) Maximum sub Functional capacity, assessed by walking test of six minutes (6MWT), following the Brazilian consensus values for the Brazilian population. 2) Pulmonary function, verified by spirometry and comparing the values of the Brazilian spirometry consensus for the Brazilian population. 3) Quality of life as measured by KDQOL-SF36, and comparing to the initial parameter values for the classification of the level of quality of life.;1) Expected Outcome: Gain maximum sub functional capacity before and after the intervention, analyzed the difference in the two periods Outcome found: Improves the distance covered on the test in both groups, but was not found statistically significant difference. 2) Expected Outcome: Pulmonary function before and after the intervention, analyzed the difference in the two periods Outcome found: Improvement in forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) in both groups, but was not found statistically significant difference. 3) Expected Outcome: Quality of life before and after the intervention, analyzed the difference in the two periods. Outcome found: Improved level of quality of life in both groups, but was not found statistically significant difference.

Countries

Brazil

Contacts

Public ContactSimone Posser

Universidade de Passo Fundo

si_posser@yahoo.com.br+55(54)8409-6027

Outcome results

None listed

Source: REBEC (via WHO ICTRP)